Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation
David Soto‐Iglesias(Hospital Quirón Teknon), Antonio Berruezo(Hospital Quirón Teknon), Giulio Zucchelli, Jose T. Ortiz‐Pérez(Hospital Quirón Teknon), Rosario J. Perea(Hospital Clínic de Barcelona), Markus Linhart(Hospital Universitari de Girona Doctor Josep Trueta), Diego Penela(Hospital Quirón Teknon), Juan Fernández‐Armenta(Hospital Universitario Puerta del Mar), S Prat(Universitat de Barcelona), Beatriz Jáuregui(Hospital Quirón Teknon), Óscar Cámara(Universitat Pompeu Fabra), Xavier Bosch(Universitat de Barcelona), Juan Acosta(Hospital Universitario Virgen del Rocío), Fátima Záraket(Hospital Quirón Teknon), Cheryl Terés(Hospital Quirón Teknon), Vladimir Syrovnev(Hospital Clínic de Barcelona)
Cited by 138
Related Papers
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
|Journal of the American College of Cardiology|2013|631
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
|Radiographics|2010|490
A global benchmark of algorithms for segmenting the left atrium from late gadolinium-enhanced cardiac magnetic resonance imaging
|Medical Image Analysis|2020|475
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461
Gender Differences in Clinical Manifestations of Brugada Syndrome
|Journal of the American College of Cardiology|2008|280